BELLUS Health Inc (TSE:BLU) will issue its quarterly earnings data on Tuesday, August 8th.

BELLUS Health Inc (TSE:BLU) opened at 0.37 on Tuesday. BELLUS Health Inc has a 52-week low of $0.21 and a 52-week high of $0.55. The stock’s 50 day moving average price is $0.40 and its 200-day moving average price is $0.33. The stock’s market capitalization is $24.74 million.

COPYRIGHT VIOLATION NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/08/01/bellus-health-inc-blu-set-to-announce-quarterly-earnings-on-tuesday.html.

In related news, Director Roberto Bellini bought 225,000 shares of the company’s stock in a transaction that occurred on Friday, July 14th. The shares were purchased at an average cost of C$0.35 per share, with a total value of C$78,750.00.

About BELLUS Health

BELLUS Health Inc is a drug development company focused on rare diseases. The business activities of the Company are development of the Company’s core technology platform, amyloid inhibitors, which focus on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils, which are the underlying causes of certain diseases.

Receive News & Ratings for BELLUS Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.